CPL207-280, a Potent and Safe GPR40 Agonist for the treatment of Type 2 Diabetes

被引：2
|
作者：
Bazydlo-Guzenda, Katarzyna
Buda, Pawel
Kozlowska, Izabela
Mach, Mateusz
Teska-Kaminska, Malgorzata
Stelmach, Filip
Wasinska-Kalwa, Malgorzata
Galazka, Kinga
Dubiel, Krzysztof K.
Pieczykolan, Jerzy S.
Wieczorek, Maciej
机构：
来源：
DIABETES | 2019年 / 68卷
关键词：
D O I：
10.2337/db19-2333-PUB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2333-PUB
引用
收藏
页数：2
相关论文
共 50 条
  • [11] GPR40 full agonists for the treatment of type 2 diabetes
    Player, Mark
    Meegalla, Sanath
    Huang, Hui
    Martin, Tonya
    Xu, June Zhi
    Zhao, Shuyuan
    Liu, Jianying
    Towers, Meghan
    Gunnet, Joseph
    Wang, Yuanping
    Lee, Seunghun
    Silva, Jose
    Otieno, Monicah
    Arnoult, Eric
    Pocai, Alessandro
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [12] Discovery of a novel potent GPR40 full agonist
    Meegalla, Sanath K.
    Huang, Hui
    Martin, Tonya
    Xu, June
    Zhao, Shuyuan
    Liu, Jianying
    Hall, Meghan
    Gunnet, Joe
    Wang, Yuanping
    Rady, Brian
    Silva, Jose
    Otieno, Monicah
    Arnoult, Eric
    Lee, S. Paul
    Pocai, Alessandro
    Player, Mark R.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (04) : 720 - 726
  • [13] Activation of GPR40 as a Therapeutic Target for the Treatment of Type 2 Diabetes
    Burant, Charles F.
    DIABETES CARE, 2013, 36 : S175 - S179
  • [14] Cyclohexyl GPR40 full agonists for the treatment of type 2 diabetes
    Meegalla, Sanath
    Lanter, James
    Huang, Hui
    Lee, Seunghun
    Martin, Tonya
    Silva, Jose
    Otieno, Monicah
    Rady, Brian
    Norquay, Lisa
    Xu, June
    Qi, Jensen
    Rankin, Matt
    Wang, Yuanping
    Zhao, Shuyuan
    Arnoult, Eric
    Gong, Yong
    Liu, Jianying
    Fran, Xu
    Du, Fuyong
    Lohani, Sachin
    Pocai, Alessandro
    Player, Mark
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [15] Optimization of GPR40 Agonists for Type 2 Diabetes
    Liu, Jiwen
    Wang, Yingcai
    Ma, Zhihua
    Schmitt, Mike
    Zhu, Liusheng
    Brown, Sean P.
    Dransfield, Paul J.
    Sun, Ying
    Sharma, Rajiv
    Guo, Qi
    Zhuang, Run
    Zhang, Jane
    Luo, Jian
    Tonn, George R.
    Wong, Simon
    Swaminath, Gayathri
    Medina, Julio C.
    Lin, Daniel C. -H.
    Houze, Jonathan B.
    ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (05): : 517 - 521
  • [16] Discovery and development of a selective GPR40/FFAR1 agonist, Fasiglifam, for the treatment of type 2 diabetes
    Tsujihata, Yoshiyuki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 : 72P - 72P
  • [17] AMG 837: A potent, orally bioavailable GPR40 agonist
    Houze, Jonathan B.
    Zhu, Liusheng
    Sun, Ying
    Akerman, Michelle
    Qiu, Wei
    Zhang, Alex J.
    Sharma, Rajiv
    Schmitt, Michael
    Wang, Yingcai
    Liu, Jiwen
    Liu, Jingian
    Medina, Julio C.
    Reagan, Jeff D.
    Luo, Jian
    Tonn, George
    Zhang, Jane
    Lu, Jenny Ying-Lin
    Chen, Michael
    Lopez, Edwin
    Nguyen, Kathy
    Yang, Li
    Tang, Liang
    Tian, Hui
    Shuttleworth, Steven J.
    Lin, Daniel C. -H.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (02) : 1267 - 1270
  • [18] Differentiation of Partial and Full GPR40 Agonists for the Treatment of Type 2 Diabetes
    Lee, Seunghun P.
    Martin, Tonya
    Huang, Hui
    Meegalla, Sanath
    Rady, Brian
    Xu, June
    Zhao, Shuyuan
    Bakaj, Ivona
    Liu, Jianying
    Towers, Meghan
    Wang, Yuanping
    Gunnet, Joseph
    Player, Mark
    Pocai, Alessandro
    DIABETES, 2016, 65 : A536 - A536
  • [19] GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus: Benefits and Challenges
    Mohammad, Sameer
    CURRENT DRUG TARGETS, 2016, 17 (11) : 1292 - 1300
  • [20] GPR40 agonists for the treatment of type 2 diabetes: From the laboratory to the patient
    Hamdouchi, Chafiq
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
12345